AU3998799A - Treatment for hemophilia - Google Patents

Treatment for hemophilia

Info

Publication number
AU3998799A
AU3998799A AU39987/99A AU3998799A AU3998799A AU 3998799 A AU3998799 A AU 3998799A AU 39987/99 A AU39987/99 A AU 39987/99A AU 3998799 A AU3998799 A AU 3998799A AU 3998799 A AU3998799 A AU 3998799A
Authority
AU
Australia
Prior art keywords
hemophilia
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39987/99A
Inventor
Gordon A Vehar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU3998799A publication Critical patent/AU3998799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU39987/99A 1998-05-20 1999-05-17 Treatment for hemophilia Abandoned AU3998799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8200098A 1998-05-20 1998-05-20
US09082000 1998-05-20
PCT/US1999/010872 WO1999059622A1 (en) 1998-05-20 1999-05-17 Treatment for hemophilia

Publications (1)

Publication Number Publication Date
AU3998799A true AU3998799A (en) 1999-12-06

Family

ID=22167779

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39987/99A Abandoned AU3998799A (en) 1998-05-20 1999-05-17 Treatment for hemophilia

Country Status (2)

Country Link
AU (1) AU3998799A (en)
WO (1) WO1999059622A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816201A1 (en) 2006-02-06 2007-08-08 CSL Behring GmbH Modified coagulation factor VIIa with extended half-life

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0568537B1 (en) * 1990-10-31 1998-02-04 Somatix Therapy Corporation Genetic modification of endothelial cells
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex
US5681746A (en) * 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII

Also Published As

Publication number Publication date
WO1999059622A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AUPP427398A0 (en) Improved disinfection
AU6200999A (en) Treatment for fabrics
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU1772399A (en) Well treatment
AU3242299A (en) Waste treatment system
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
AU8363398A (en) Capotasto
AU2609599A (en) Sensor-coupling
AU2069199A (en) Codelets
AU3204999A (en) Futureball
AU8386098A (en) Orthopedic supports
AU5223199A (en) Bathtub-bathseat
AU1055399A (en) Rollerboard
AU3998799A (en) Treatment for hemophilia
AU5524399A (en) Inorgasmia treatment
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU2840799A (en) 1-phosphanorbornadienes
AU3819799A (en) Methoximinomethyloxathiazines
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase